| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.676 | 19.009 | 36.466 | 39.012 | 60.176 |
| Total Income - EUR | - | - | - | - | - | 2.676 | 19.009 | 36.466 | 39.022 | 60.200 |
| Total Expenses - EUR | - | - | - | - | - | 2.244 | 13.572 | 21.344 | 29.153 | 52.908 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 432 | 5.437 | 15.122 | 9.868 | 7.293 |
| Net Profit/Loss - EUR | - | - | - | - | - | 352 | 5.246 | 14.578 | 9.478 | 5.487 |
| Employees | - | - | - | - | - | 0 | 3 | 2 | 3 | 2 |
Check the financial reports for the company - Mitogenix Innovations S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 31.284 |
| Current Assets | - | - | - | - | - | 515 | 6.188 | 16.701 | 12.208 | 18.905 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 520 |
| Receivables | - | - | - | - | - | 41 | 1.890 | 14.017 | 11.334 | 4.497 |
| Cash | - | - | - | - | - | 473 | 4.298 | 2.683 | 874 | 13.888 |
| Shareholders Funds | - | - | - | - | - | 393 | 5.639 | 14.627 | 9.526 | 5.535 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 122 | 549 | 2.074 | 2.682 | 44.653 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Mitogenix Innovations S.r.l.